ArticleDrug development research2025
Multilayer Antibacterial Hydrogel Wound Dressings Incorporated With Green Synthesized Silver Nanoparticles.
Article in Drug development research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Antibacterial and antioxidant okra-based hydrogels enhanced with Ag@HKUST-1 as a next-generation wound dressing.International journal of pharmaceutics: X · 2026Article
- Review
- Transparent Elastic Wound Dressing Gel Supporting Drug Release: Synergistic Effects of Poly(Vinyl Alcohol)/Chitosan Hybrid Matrix.Gels (Basel, Switzerland) · 2025Article
- Polymeric Systems as Hydrogels and Membranes Containing Silver Nanoparticles for Biomedical and Food Applications: Recent Approaches and Perspectives.Gels (Basel, Switzerland) · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Multilayer antibacterial hydrogel wound dressings were fabricated and characterized for wound healing applications. Dressings are designed to achieve infection control, moisture management in the wound area and to support wound healing. Multilayer wound dressings were prepared as three layers by solvent casting method. The upper layer is composed of kappa carrageenan and green synthesized silver nanoparticles (AgNPs, ~122 nm in size, zeta potential of -35 mV) to provide the moist control, and to form a barrier against microorganism attack. Lidocaine HCl loaded polyvinyl alcohol and chitosan-based middle layer was designed to achieve controlled drug release and to add strength to the hydrogel structure. The lower layer is composed of hyaluronic acid and ovalbumin to serve a controlling membrane for controlled drug release, and to further support wound healing. Different amounts of AgNPs were used in formulations to evaluate their impact on multilayer wound dressings. The incorporation of AgNPs resulted in reduced swelling values and degradation rates of the multilayer wound dressings, enhanced mechanical capabilities, and no significant change in water vapor permeability values. They have demonstrated enhanced antibacterial efficacy against Klebsiella pneumoniae, Bacillus subtilis and Candida albicans. The optimal multilayered hydrogel, incorporating AgNPs and loaded with lidocaine HCl, has shown biocompatibility and hemocompatibility, exhibiting 60% degradation by day 14, water vapor permeability of 2022 ± 460 g/m
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.